醫(yī)學(xué)資料 腎病業(yè)務(wù)學(xué)習(xí)課件_第1頁(yè)
醫(yī)學(xué)資料 腎病業(yè)務(wù)學(xué)習(xí)課件_第2頁(yè)
醫(yī)學(xué)資料 腎病業(yè)務(wù)學(xué)習(xí)課件_第3頁(yè)
醫(yī)學(xué)資料 腎病業(yè)務(wù)學(xué)習(xí)課件_第4頁(yè)
醫(yī)學(xué)資料 腎病業(yè)務(wù)學(xué)習(xí)課件_第5頁(yè)
已閱讀5頁(yè),還剩42頁(yè)未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

Case24-year-old,maleMaincomplaintsRepeatedgrosshematuria

for4yrs

HistoryofPresentIllness:Theptsfoundhisurinearebrown,1dayafterupperrespirationinfection.thegrosshematuriacoulddisappearafterthetreatmentwithantibiotics.thesymptomrepeated1~2timesayear.Case

betweentheepisode,urineanalysis:persistentproteinuriaandhematuria(

Pro+BLD3+)Lab:IgG:576↓,IgA:142,IgE:<28.3C3:111,C4:27.8

BUN:13,Crea:0.6,albumin:3.9DPL:1911mg/day

renalbiopsy:IgAnephropathyWhatisIgAnephropathy?Whatisthereason

ofIgAN?WhyhegetsIgAN?HowtotreatIgAN?Whataboutit'sprognosis?IssueIgANephropathyDefinitionIgAmeansimmunoglobulinA,IgAnephropathy(IgAN)isakidneydisorderthatoccurswhenIgA—aproteinthathelpsthebodyfightinfections—settlesinthekidneys.IgAnephropathy

Firstreportedin1968,alsocalledBerger’sDiseasethecommonestprimaryGNvariable:

incidencearedifferentindifferentcountriesandraces

multiformityinclinicalmanifestation,andprognosisIgAnephropathyFinaldiagnosisisdependedon

ImmunofluorescencemicroscopyofrenalbiopsyGreatestfrequencyinCaucasiansandAsians.DiseaseprevalencemayinpartreflectregionalRenalbiopsypractices.Incidence

★SouthAmerica10%

Europe

20%

AsiaandPacific30-40%

China30%±m(xù)ale>femaleOccuratallagespredominate:olderchildrenandyoungadults,20+~30+y/o:↑thecommoncauseofCRFEtiologyMostcasesareidiopathicSLE,Sch?nlein-Henoch

SyndromLivercirrhosis.Glutenenteropathy(非熱帶性口炎性腹瀉).HIVinfection.Wegener’sgranulomatosistreatedwithimmunosuppressiveagentsandURI(upperrespiratoryinfection).Familial.Dermatitisherpatiformis(皰疹性皮炎)

andseronegativearthritis(血清陰性關(guān)節(jié)炎),

psoriasis

(牛皮癬).Gougerot-Houwesyndrome(干燥綜合征)PathogenesisUnknow:whatcausesIgAdepositstoforminthekidneys

.IgAnephropathymayruninfamiliesorberelatedtorespiratoryinfections.NoconsistenttriggerforthediseasehasbeenfoundAbnormalityofIgAregulationinresponsetoanenvironmentalantigen.PlasmaIgAconcentrationincreasedin50%ofcases.DirectcorrelationtocirculationIgAcomplexesanddiseaseseverity.IncreaseinIgA-specificBandTLymphocytesinresponsetoURI(upperrespiratoryinfection).Decreasedmucosalimmunity.IgAimmunecomplexactivatesalternatecomplementpathwaythuseliminationbymonocyte-macrophagesystemisslowandmorecomplexesareavailabletobedepositedontheglomerularmembrane.AlteredstructureofIgAcomplexesandelectrostaticchargealsoslowstheclearancemechanism.IgA-immunecomplexbindstofibronectinwhichhelpsinclearanceafterbindingwithuteroglobin.Abnormaluteroglobinorimpairedproductionpreventsclearance.PathologyLightmicroscopyfindingfocalordiffusemesangialproliferationandmatrixexpansion.Minorglomerularchang(20%),FSGS(28%),mesangialproliferativenephritis(50%),focalsegmentalglomerulonephritis,necrotizingglomerulonephritis,mesangiocapillary

glomerulonephritis,crescentic

glomerulonephritis,GlobulardepositsofIgA(alongwithC3andIgG)asdemonstratedbyImmunofluorescencemicroscopyinthemesangiumandglomerularcapillarywall.Electronmicroscopyshowingelectrondensedepositsofmesangium.Mesangialelectrondensedepositswith↑mesangialmatrix&cellularityinIgANClinicalPresentationClinicalfeature:1.predilectioninyoungmen:

predominate:13~15yr2.

manyptswithforerunnerinfectionbeforeepisodeorrelapse3.

hematuriaisverycommon一、hematuria:infectionortired40to50%presentwithrecurrentgrosshematuria.30to50%withmicroscopichematuriaandprotienuria.20to25%progresstogrosshematuria.二、proteinuriawithorwithoutmicroscopichematuria

thecommonestclinicalfeature(>50%)三、nephroticsyndrome

about3~4%,

areportinChina16.7%

四、Hypertension

AdultIgA>50%,children

5%。

about6yrsbeforerenalfailure。somepatientsmalignanthypertension五、Chronicrenalfailure10~20yrsafterdignosis,someptsatthefirstvisit。六、Acuterenalfailure(<10%)

1.ATN:RBCblockkidneytubules

2.Acutenephriticsyndrome,transientRF,pathologyissameasAGN3.Rapidlyprogressiveglomerulonephritis,

RPGN,progressiverenalfunctiondeteriorationFiveClinicalsyndromes1.Grosshematuria2.Asymptomaticmicroscopichematuriawith/withoutproteinuria----62%3.Acutenephritiswithhypertensionand/orrenalinsufficiency4.Nephroticsyndrome5.Amixednephritic-nephroticsyndromeLaboratoryexaminationUA:hematuria,proteinuriaserumIgA

↑(30~70%,China10~30%)

IgG,IgMarenormal,C3,CH50arenormalorslightly↑IgA-FN↑,IgA-IC↑someptswithHBsAgpositive

Diagnosisimmunohistochemicalfindingsof

mesangialdepositionofIgAlightmicroscopy:mesangialcell

proliferationisthecommonestfeatureDifferentialdiagnosis

1.post-streptococcalGN(AGN)latentperiodof10-21daysaffectchildrenprincipally,

hematuriaprincipally,hypertensiontransientrenalinsufficiencyCH50andC3lowbutnormalisesafter6-8weeks

2.chronicGN(non-IgA)

3.hereditaryGN

4.secondaryIgAN

Henoch-Sch?nleinpurpuraLupusnephritisHenoch-Sch?nleinpurpuraHenoch-Sch?nleinpurpura(HSP)HSP:clinicalsyndromeSame:histopathologicalalterationsDifference:HSPhassystemicsymptoms:purpuricrash,arthralgias,abdominalpain,acuteonset,self-limited.VariantsofthesamepathophysiologicprocessTreatmentGoal:preventprogressionofdiseaseandprotectrenalfunctionaccordingtotheclinicalfeatureandpathologictype

ACEInhibitorsCorticosteroidsImmunosuppressantsFish-oilsupplementTonsillectomy1、Hematuriaormildproteinuria

Forpatientswithnormalrenalfunction,

normotensionandonlyminorurinary

abnormalities,suchasisolatedmicroscopic

haematuria,and/ormildproteinuria,thegeneral

consensusisnottoofferspecifictreatmentbutto

keepsuchpatientsunderreview.

Upto23%ofpatientswillhaveaspontaneous

completeremission.TonsillectomyIgA:mucosadefensePopularinJapanandFrance.Indication:chronicinfections(dentalabscess,sinusitis)Inpediatric:tonsillectomy:↓grosshematuriaepisodes.NoevidenceforaffecttheprogressiontoCRIorESRD.Recommended:controversial2、massproteinuriaorNS3、Rapidlyprogressiveglomerulonephritis,RPGN

4、Chronicglomerulonephritistreattheinfectionantiplateletadhesiveness、anticoagulationeicosapentaenoicacid(一種魚油,3-ω脂肪酸):postponeprogressofrenalfibrinolyticagent——urokinase,reduceth

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論